Detection of BCR-ABL-Positive Cells in the Colostrum of a Pregnant Patient with Chronic Myeloid Leukemia

被引:1
|
作者
Hiroshima, Yuki [1 ]
Tajima, Katsushi [1 ]
Shiono, Yousuke [1 ]
Suzuki, Ikuko [1 ]
Kouno, Kei [1 ]
Katou, Yuuichi [1 ]
Kato, Takeo [1 ]
机构
[1] Yamagata Univ, Sch Med, Dept Internal Med 3, Yamagata 990, Japan
关键词
chronic myeloid leukemia (CML); pregnancy; breast feeding; colostrum; BCR-ABL; cord blood; ORAL IMMUNE TOLERANCE; OF-THE-LITERATURE; CORD BLOOD; ANTIGENS; LEUKAPHERESIS; TRANSMISSION; MANAGEMENT; CANCERS; GROWTH; CML;
D O I
10.2169/internalmedicine.50.5785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 31-year-old pregnant woman was diagnosed with chronic-phase chronic myeloid leukemia at gestational week 16. To avoid exposure of the fetus to teratogenic agents, the patient opted for a course of careful observation only for the duration of her pregnancy. We detected 9.1% of BCR-ABL-positive cells in the patient's colostrum with fluorescence in situ hybridization.
引用
收藏
页码:2389 / 2391
页数:3
相关论文
共 50 条
  • [1] Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia
    Thijsen, SFT
    vanOostveen, JW
    Schuurhuis, GJ
    Theijsmeijer, AP
    Oudejans, CBM
    vanWijk, IJ
    Langenhuijsen, MMAC
    Ossenkoppele, GJ
    LEUKEMIA, 1997, 11 (10) : 1762 - 1768
  • [2] Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia
    SFT Thijsen
    JW van Oostveen
    GJ Schuurhuis
    AP Theijsmeijer
    CBM Oudejans
    IJ van Wijk
    MMAC Langenhuijsen
    GJ Ossenkoppele
    Leukemia, 1997, 11 : 1762 - 1768
  • [3] Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
    Preisinger, C.
    Schwarz, J. P.
    Bleijerveld, O. B.
    Corradini, E.
    Mueller, P. J.
    Anderson, K. I.
    Kolch, W.
    Scholten, A.
    Heck, A. J. R.
    LEUKEMIA, 2013, 27 (03) : 743 - 746
  • [4] Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
    C Preisinger
    J P Schwarz
    O B Bleijerveld
    E Corradini
    P J Müller
    K I Anderson
    W Kolch
    A Scholten
    A J R Heck
    Leukemia, 2013, 27 : 743 - 746
  • [5] 3′ BCR recombines with IGL locus in BCR-ABL-positive philadelphia-negative chronic myeloid leukemia
    Benjes, SM
    Millow, LJ
    Jeffs, AR
    Sowerby, SJ
    Reeve, AE
    Morris, CM
    GENES CHROMOSOMES & CANCER, 1999, 26 (04): : 366 - 371
  • [6] Monitoring minimal residual disease in BCR-ABL-positive chronic myeloid leukemia in the imatinib era
    Goldman, J
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 33 - 39
  • [7] Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman, Marshall A.
    ONCOLOGIST, 2008, 13 (06): : 645 - 654
  • [8] Dendritic cells for vaccination in BCR/ABL positive chronic myeloid leukemia.
    Westermann, J
    Richter, G
    Kopp, J
    Körner, I
    Döhner, H
    Döhner, K
    Dörken, B
    Pezzutto, A
    BLOOD, 1999, 94 (10) : 281B - 281B
  • [9] No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogeneic transplantation for chronic myeloid leukemia
    Deininger, M
    Lehmann, T
    Krahl, R
    Hennig, E
    Müller, C
    Niederwieser, D
    BLOOD, 2000, 96 (02) : 778 - 779
  • [10] ABL-BCR expression in BCR-ABL-positive human leukemia cell lines
    Uphoff, CC
    Habig, S
    Fombonne, S
    Matsuo, Y
    Drexler, HG
    LEUKEMIA RESEARCH, 1999, 23 (11) : 1055 - 1060